Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
International Research Collaboration Reveals Promising Drug Candidate for Treatment of Blood Cancers
Details : OncoTartis, and Children's Cancer Institute jointly announced the publication of two research manuscripts in onco-hematological journal Leukemia, devoted to the OncoTartis' clinical candidate OT-82.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 16, 2020
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Details : OT-82 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Lymphoma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 19, 2019